Skip to main content

Prevención y tratamiento de la muerte súbita cardíaca basados en mapeo cardíaco de alta precisión: resultados personalizados a través de una localización optimizada (APOLO)

CPP2023-010504

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Transferencia de Conocimiento
Call Proyectos en Colaboración Público-Privada
Call year 2023
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre CORIFY CARE S.L.

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Validation of an imageless electrocardiographic imaging technique for the non-invasive mapping of regular atrial tachyarrhythmias

  • Reventós-Presmanes, Jana
  • Cano-Cabañero, Andrea
  • Invers-Rubio, Eric
  • Pellicer-Sendra, Berta
  • Serrano-Campaner, Jaume
  • Zacur, Ernesto
  • Althoff, Till F
  • Hernández-Romero, Ismael
  • Borràs, Roger
  • Regany-Closa, Mariona
  • Arbelo, Elena
  • Guasch, Eduard
  • Tolosana, Jose María
  • Porta-Sánchez, Andreu
  • Herrero-Martín, Clara|||0000-0001-5053-296X
  • Andreu M. Climent|||0000-0002-7260-8811
  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
[EN] This study validates the clinical performance of an imageless ECGi system for the characterization of regular atrial tachyarrhythmias. Its ability to provide rapid, full-chamber activation maps from a single beat may make it a potential solution for mapping transient arrhythmias or rhythm changes during ablation procedures., This project has been funded by grants PID2023-149812OB-I00, DIN2024-013365, PTQ2023-013018, PTQ2022-012632, RYC2018-024346-I, CNS2022-135512, and CPP2023-010504 funded by Ministerio de Ciencia, Innovacion y Universidades MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/Plan de Recuperacion, Transformacion y Resiliencia. This project has been funded by Generalitat Valenciana by grants ACIF/2021/205 and CIAICO/2022/020 and by European Social Fund Investing in Your Future. This project also received funding from European Institute of Innovation and Technology (EIT Health) (activity codes 220385, 230129, and 250027). Additionally, this work was supported by a research grant from Instituto de Salud Carlos III, which is co-funded by the European Union (grant PI22/00441). J.-B.G. acknowledges support from the grants 'Contractes d'Investigacio Avancada Fundacio BBVA' - Hospital Clinic Barcelona Joan Rodes-Josep Baselga 2022' (HCB_BIO_001/2) and the 'Daniel Bravo Andreu Private Foundation 2024 Grants' for short stays abroad in biomedical research.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Noninvasive assessment of the ventricular arrhythmogenic substrate using electrocardiographic imaging during sinus rhythm: The NIAVAS study

  • Reventós-Presmanes, Jana
  • Hernández-Romero, Ismael
  • Pecllier-Sendra, B.
  • Guillen-Buisan, E.
  • Serrano-Campaner, J.
  • Invers-Rubio, E.
  • Regany-Closa, M.
  • Garre, Paz
  • Borras, Roger
  • Costafreda, Adriana
  • Arbelo, Elena
  • Tolosana, Jose M.
  • Guasch, E.
  • Althoff, Till F.
  • Guichard, Jean-Baptiste
  • Falzone, Pasquale V.
  • Vázquez-Calvo, Sara
  • Elivhots Ayauja
  • Porta-Sanchez, Andreu
  • Roca-Luque, Ivo
  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
  • Andreu M. Climent|||0000-0002-7260-8811
[EN] Background Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) identifies structural properties associated with ventricular tachycardia (VT) but lacks functional information. Noninvasive identification of slow conduction regions using electrocardiographic imaging (ECGI) could complement LGE-CMR to aid VT risk stratification. Objective This study aimed to evaluate the relationship between ventricular arrhythmogenic substrate and regional ECGI markers during sinus rhythm in patients with ischemic cardiomyopathy (ICM). Methods Seventy-two patients were included: 29 with ICM evidenced by LGE-CMR referred for VT ablation, 17 with ICM with implantable cardioverter-defibrillator for primary prevention without documented VT, and 26 controls. ECGI-derived regional activation dispersion (rAD) and pseudo-regional conduction velocity (pseudo-rCV) were analyzed and compared between scarred and healthy regions based on LGE, and between patients with ICM with and without previous VT. In a subgroup with electroanatomic mapping (n = 16), deceleration zones were correlated with ECGI. Results Scarred regions showed higher rAD (46.3 ± 2.2 vs 30.1 ± 1.7 ms, P < .001) and reduced pseudo-rCV (149.9 ± 3.0 vs 165.7 ± 2.4 cm/s, P < .001) than healthy regions. In the subgroup with sinus rhythm electroanatomic mapping, regions containing deceleration zones showed increased rAD (64.9 ± 5.4 vs 43.1 ± 3.1 ms, P < .001), and ECGI identified 70.4% of those zones. At the patient level, the mean of the 3 regions with the highest activation dispersion differentiated patients with ICM with and without previous VT (rAD ¿60.0 ms, sensitivity 75.9%, area under the curve [AUC] 0.75, P = .005) and identified patients with ICM from controls (rAD ¿39.5 ms, AUC 0.93). Conclusion This study introduces a novel regional ECGI methodology demonstrating that rAD identifies abnormalities linked to arrhythmogenic substrate and could help identify patients at risk of VT. These findings highlight ECGI¿s potential as a complementary tool to LGE-CMR., This research was funded by the European Institute of Innovation and Technology (EIT Health) under grant agreement no. 230129. In addition, the research was supported by Ministerio de Ciencia, Innovación y Universidades MCIN/AEI/10.13039/501100011033 (grant PID2023-149812OB-I00), European Union NextGenerationEU/Plan de Recuperación, Transformación y Resiliencia (CNS2022-135512, PTQ2023-013018, and CPP2021- 008562), and Fondo Europeo de Desarrollo Regional European Union (CPP2023-010504). Additional support came from Generalitat Valenciana and European Social Fund Investing in Your Future (grants CIAPOS/2021/238 and CIAICO/2022/020), Instituto de Salud Carlos III (grant CIBERCV16 CB16/11/00354), and Catalonia, Spain (grants 2021_SGR_01350 and SGR21/GENCAT).